Rhythm Pharmaceuticals (RYTM) PT Raised to $37 at Stifel on Early, But 'Fantastic' HO Data
Tweet Send to a Friend
Stifel analyst Dae Gon Ha raised the price target on Rhythm Pharmaceuticals (NASDAQ: RYTM) to $37.00 (from $25.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
